| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 |
| Profit before tax | -2.6 | -1.7 |
| Net income | -2.6 | -1.7 |
| EPS (diluted, $ a share) | $-0.94 | $-2.93 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | +78.1% |
|---|---|
| Gross margin | 43.9% |
Source
Read the filing ↗
10-Q filed with the SEC, NASDAQ: ACON. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Aclarion, Inc.: key numbers
- Share price
- $1.39Close, Nov 16
- Market cap
- $4.01M
- Shares outstanding
- 2.88MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Medical LaboratoriesSIC 8071
Today's reference numbers, updated daily. Not a valuation or a recommendation.